Olympus Capital Holdings Asia
GIC, Olympus lead Series D round in China premium dairy play
Singapore sovereign wealth fund GIC Private and Olympus Capital Asia have led a $106 million Series D round of investment in China's Huaxia Dairy in a bid to tap in the country's fast-growing premium dairy segment.
Permira targets IPO for Japan’s Arysta LifeScience – report
Permira is planning to raise $500 million via the US IPO of Japanese agricultural chemical maker Arysta LifeScience.
Olympus leads $65m round for India's DM Healthcare - report
Indian hospital chain Aster DM Healthcare is said to be raising $65 million from existing backers Olympus Capital Asia and India Value Fund Advisors (IVFA).
IFC commits $25m to Olympus' Asia environment fund
International Finance Corporation (IFC), the investment arm of the World Bank, plans to invest $25 million in Olympus Capital Asia’s latest pan-regional environment fund. The vehicle has a target size of $300 million.
IVF-backed ACT gets OCA Credit, Kilimanjaro debt solution
Atria Convergence Technologies (ACT), an Indian broadband and cable TV access provider backed by India Value Fund Advisors (IVFA), has received structured debt financing from Olympus Capital Asia Credit (OCA Credit) and Kilimanjaro Credit Fund.
Carlyle to exit Yashili stake to China Mengniu Dairy
The Carlyle Group has agreed to sell its 24% stake in Yashili International to domestic rival China Mengniu Dairy for about HK$3 billion ($387 million). This is part of a Mengniu bid for a majority interest in Yashili - its second lateral investment...
Safety first: Investing in China's food supply chain
Driven by rising disposable incomes and lower confidence in food safety, Chinese consumers are willing to pay a premium for quality. PE firms have identified the opportunity, but taking it can be difficult
Olympus Capital launches Asia structured credit business
Olympus Capital Asia is entering the structured credit space, with a particular focus on Southeast Asia, India and Australia. Daniel Mintz, the private equity firm’s founding managing director, believes the pullback by commercial banks combined with...
Healthy holidays: PE and medical tourism
Asia’s medical tourism sector is growing rapidly as visitors flock east for cheap surgical procedures. How big is the opportunity for private equity and where can it be found?
Sequoia invests $9.3m in Indian eye hospitals
Sequoia Capital has invested INR500 million ($9.3 million) in ASG Eye Hospitals, a Rajastan-based group of specialty eye hospitals. The funding will be used by the company to support expansion into central and northern India.
Olympus-backed DM Healthcare targets IPO by 2015
Olympus Capital-backed DM Healthcare, a Dubai-based healthcare services provider which gets a majority of its business in the Middle East, aims to go public by 2015.
PE investors inject $50m into Huaxia Dairy
Olympus Capital has led a group investors including California Technology Ventures, Herostar Holdings and Grand River Capital in committing $50 million stake in Chinese milk producer Huaxia Dairy Farm.
CRCI sells Grant Achieve Global stake to Olympus Capital
China Renaissance Capital Investment (CRCI) and the chairman of Chinese water treatment firm Grant Achieve Global (GAG) have sold a 40% holding in the company to Olympus Capital Holdings Asia and Anoi, a Hong Kong-incorporated enterprise.
Corporate Japan more open to PE partnerships – AVCJ Forum
Corporate Japan is more open to the idea of working with private equity partners, but ensuring alignment of interests remains a challenge, according to David Shen, regional managing director of Olympus Capital Holdings Asia.
UPDATE: PE group invests another $150m in Zhaoheng Hydropower
Morgan Stanley Infrastructure Partners, Fountainvest Partners and Olympus Capital have together invested $150 million in Shenzhen-based Zhaoheng Hydropower, matching a commitment they made two years ago. The total consideration is said to be the largest...
Olympus-backed DM Healthcare outlines India spending plans
Olympus-backed DM Healthcare, a Dubai-based healthcare services provider which gets a majority of its business in the Middle East, will invest INR15 billion ($270 million) in India. The company hopes this will help boost overall revenues by 40% to INR23...
Moolchand raises $18.7m from Sequoia Capital
Sequoia Capital has invested INR1 billion ($18.7 million) into New Delhi-based Moolchand Healthcare, with an aim to fund the company’s further expansion and acquisitions of hospitals across India.
India hospitals: Capital cure
Badly in need of consolidation and infrastructure investment, India’s hospital chains are an attractive target for private equity. But identifying suitable targets and getting them to scale up remains a challenge
Olympus Capital invests $38m in Karur Vysya
Olympus Capital Holdings Asia has bought a 4.8% stake in India’s Karur Vysya Bank for $38.34 million as part of a PIPE transaction. It comes one month after ChrysCapital invested $31 million in the bank.
Advent International to invest $105m CARE Hospitals
Advent International will invest $105 million in multi-specialty hospital chain CARE Hospitals, representing its third investment in India.
Japan’s PE firms on trade sale hunt
Japanese buyout firms are making plans to offload a portion of their local portfolio companies via trade sales this year.
GIC commits $100m to Vasan Healthcare
Government of Singapore Investment Corp. (GIC) has invested $100 million for a minority stake in Vasan Healthcare, which runs eye care hospitals across India. The transaction is the largest PE deal in the country's healthcare industry since Olympus Capital’s...
Shearwater's Stead becomes Australia head at Olympus Capital Asia
Gary Stead, co-founder and managing director of Shearwater Capital Group, has become Australia country head at Olympus Capital Asia. The move came largely as a result of the difficulties raising a new fund.
FGPI gives $41m cash boost to Aptuit Laurus
Fidelity Growth Partners India (FGPI), the India-focused the private equity arm of Fidelity Worldwide Investment, has invested INR2 billion ($40.6 million) in pharma company Aptuit Laurus.